BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 15322225)

  • 1. Analysis of CGG variation through 642 meioses in Fragile X families.
    Rifé M; Badenas C; Quintó L; Puigoriol E; Tazón B; Rodriguez-Revenga L; Jiménez L; Sánchez A; Milà M
    Mol Hum Reprod; 2004 Oct; 10(10):773-6. PubMed ID: 15322225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation and intergenerational FMR1 CGG-repeat stability in 100 unrelated three-generation families from the normal population.
    Patsalis PC; Sismani C; Stylianou S; Ioannou P; Joseph G; Manoli P; Holden JJ; Hettinger JA
    Am J Med Genet; 1999 May; 84(3):217-20. PubMed ID: 10331595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The number of CGG repeats of the FMR1 locus in premutated and fully mutated heterozygotes and their offspring: implications for the origin of mosaicism.
    Mingroni-Netto RC; Haddad LA; Vianna-Morgante AM
    Am J Med Genet; 1996 Aug; 64(2):270-3. PubMed ID: 8844063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy.
    Moore CJ; Daly EM; Tassone F; Tysoe C; Schmitz N; Ng V; Chitnis X; McGuire P; Suckling J; Davies KE; Hagerman RJ; Hagerman PJ; Murphy KC; Murphy DG
    Brain; 2004 Dec; 127(Pt 12):2672-81. PubMed ID: 15483045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragile X analysis of 1112 prenatal samples from 1991 to 2010.
    Nolin SL; Glicksman A; Ding X; Ersalesi N; Brown WT; Sherman SL; Dobkin C
    Prenat Diagn; 2011 Oct; 31(10):925-31. PubMed ID: 21717484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare variants in the promoter of the fragile X syndrome gene (FMR1).
    Milà M; Castellví-Bel S; Sánchez A; Barceló A; Badenas C; Mallolas J; Estivill X
    Mol Cell Probes; 2000 Apr; 14(2):115-9. PubMed ID: 10799273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
    Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
    J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaicism for full mutation and normal-sized allele of the FMR1 gene: a new case.
    Orrico A; Galli L; Dotti MT; Plewnia K; Censini S; Federico A
    Am J Med Genet; 1998 Jul; 78(4):341-4. PubMed ID: 9714436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of unstable DNA sequence in FMR1 gene in Polish families with fragile X syndrome.
    Milewski M; Zygulska M; Bal J; Deelen WH; Obersztyn E; Bocian E; Halley DJ; Horst J; Mazurczak T
    Acta Biochim Pol; 1996; 43(2):383-8. PubMed ID: 8862184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A genetic and molecular study of 85 families affected with the fragile X syndrome].
    Milà Recasens M; Sánchez Díaz A; Glover López G; Castellví Bel S; Carbonell Meseguer P; Kruyer H; Ballesta Martínez F; Estivill Pallejà X
    An Esp Pediatr; 1996 Mar; 44(3):250-6. PubMed ID: 8830601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The (CGG)n repeat element within the 5' untranslated region of the FMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter.
    Chen LS; Tassone F; Sahota P; Hagerman PJ
    Hum Mol Genet; 2003 Dec; 12(23):3067-74. PubMed ID: 14519687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles.
    Nolin SL; Brown WT; Glicksman A; Houck GE; Gargano AD; Sullivan A; Biancalana V; Bröndum-Nielsen K; Hjalgrim H; Holinski-Feder E; Kooy F; Longshore J; Macpherson J; Mandel JL; Matthijs G; Rousseau F; Steinbach P; Väisänen ML; von Koskull H; Sherman SL
    Am J Hum Genet; 2003 Feb; 72(2):454-64. PubMed ID: 12529854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long uninterrupted CGG repeats within the first exon of the human FMR1 gene are not intrinsically unstable in transgenic mice.
    Lavedan C; Grabczyk E; Usdin K; Nussbaum RL
    Genomics; 1998 Jun; 50(2):229-40. PubMed ID: 9653650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic behavior of fragile X full mutations in cultured female fetal fibroblasts.
    Sun YJ; Han X
    Acta Pharmacol Sin; 2004 Jul; 25(7):973-6. PubMed ID: 15210074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fragile X premutation: new insights and clinical consequences.
    Van Esch H
    Eur J Med Genet; 2006; 49(1):1-8. PubMed ID: 16473304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental therapy: reactivation of the FMR1 gene involved in fragile X syndrome].
    Chiurazzi P; Neri G
    Rev Neurol; 2001 Oct; 33 Suppl 1():S62-5. PubMed ID: 12447822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion to full mutation of a FMR1 intermediate allele over two generations.
    Terracciano A; Pomponi MG; Marino GM; Chiurazzi P; Rinaldi MM; Dobosz M; Neri G
    Eur J Hum Genet; 2004 Apr; 12(4):333-6. PubMed ID: 14735162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.